It has been verified that auranofin can induce necroptosis by inhibiting the PI3K/AKT/mTOR pathway to restrain the exacerbation of non-small cell lung cancer (NSCLC); however, additional research is needed to elucidate the underlying mechanism (200). Here, AKT1 is linked to non-small cell lung carcinoma.